Skip to main content

Advertisement

Table 3 Gastrointestinal Symptom Rating Scale Abdominal Pain Subscore

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Visit Gas Defense Placebo
Day 0 Screen/Rand 3.17 ± 1.85 (29) 3.14 ± 1.48 (29)
Day 14 Mid-Study 2.10 ± 1.29 (29) 2.28 ± 1.51 (29)
Day 29 End-of-Study 1.59 ± 0.95 (29) 2.21 ± 1.45 (29)
Change from Day 0 to Day 14 -1.07 ± 1.70 (29) -0.86 ± 1.81 (29)
Change from Day 0 to Day 29 -1.59 ± 1.70 (29) -0.93 ± 1.67 (29)
  1. Values are expressed as mean ± standard deviation.